Gerresheimer is presenting various new products at CPhI China in Shanghai from June 18 to 20, 2019 (SNIEC, booth N5P21).
The company’s comprehensive product portfolio includes insulin pens, inhalers, micropumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems.
Gx Elite Vials – top quality for even greater patient safety
With its Gx Elite vials for injectables made from type I borosilicate glass, Gerresheimer is unveiling the result of a careful product development process spanning several years. Glass-to-glass contact is avoided throughout production, ensuring that the vials are extremely shatterproof, highly robust, and free from cosmetic defects. They boast extremely accurate dimensions, while their resistance to delamination protects the drug inside. Simple handling and a range of packaging options ensure that Gx Elite vials can be supplied for end-to-end use on various filling lines. This cuts costs while improving quality, as countless past and ongoing tests by notable customers have shown.
Vials for injectables from Shuangfeng in China
Gerresheimer’s Shuangfeng site has been supplying many well-known pharmaceutical companies with tubular glass bottles for decades now. The range includes 1 ml to 50 ml bottles, 1 ml to 30 ml ampoules in various designs, and dental and insulin cartridges. The site is also home to a professional laboratory for complete glass analysis and test projects where extraction and leaching experiments can be conducted.
Gerresheimer in China and India – glass primary packaging for drugs
Gerresheimer’s Shuangfeng site in China manufactures vials, ampoules, cartridges, and other specialty products made from clear and amber glass.
In India, the company produces vials and ampoules for local and international customers. The Neutral Glass plant in Kosamba makes pharmaceutical primary packaging from moulded glass, while Gerresheimer’s Kosamba factory next door produces vials and ampoules from tubular glass.
Gerresheimer’s factories in Asia, Europe, and the Americas work closely together as part of a global network. They apply current good manufacturing practice (CGMP) principles rigorously and are certified to ISO 9001. Some plants also have ISO 15378 certification or eve higher. All Gerresheimer products comply with the relevant pharmacopeias (Ph. Eur., USP, and JP).
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.